Loading…

Gemini Bioproducts opened a new 25,000-square-foot cGMP manufacturing facility in West Sacramento, California, quadrupling production capacity for cell culture reagents.
“Gemini Bio’s new facility was built to support the production of cell culture media, sera, buffers, and other reagents with products that serve the cell and gene therapy market.”newswire.com
Summarized from public sources; check the original articles before acting on it.